Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe
Mr. Tyson's session, titled "After EDC Implementation: Now What?" isslated for 29 May at 14:50. The session, designed to help clinical leadersunderstand how organizations can ensure successful uptake of EDC solutions andmaximize returns on EDC investments, will cover
"Although the initial rollout of a clinical EDC solution can be cause forcelebration, it doesn't mean that the work is over," Mr. Tyson said. "Tofully realize the potential benefits of EDC, clinical organizations mustproperly integrate key activities and processes with the system."
As head of Campbell Alliance's Clinical Development Practice, Gary Tysonleads a team that provides a range of operational improvement services toclinical development organizations within pharmaceutical and biotechcompanies, as well as leading contract research organizations (CROs). Mr.Tyson is a veteran of numerous EDC-related initiatives, including helpingorganizations adopt EDC at the enterprise level, and brings a wealth ofknowledge and experience in process improvement, organizational design, andclinical development to his consulting engagements.
For more information on Informa's Clinical Trials Congress, Europe, pleasevisit www.informa-ls.com/ctc . Executives from Campbell Alliance speak atmany conferences in the US and Europe each year. For a full listing ofevents, please refer to the company's online conference calendar athttp://www.campbellalliance.com/pressroom/eventcalendar.cfm .
About the Clinical Development Practice at Campbell Alliance
Campbell Alliance's Clinical Development Practice includes operationsimprovement specialists with expertise in clinical development. The practicespecializes in helping clients correct or improve the processes that are mostoften responsible for delays and budget overruns in clinical development.Services include
About Campbell Alliance
Campbell Alliance is the leading management consulting firm specializingin the pharmaceutical and biotechnology industry. The firm's clients includemost of the world's top-20 pharmaceutical companies, as well as numerousemerging and midsize firms. Campbell Alliance is organized into practiceareas, each specializing in a critical industry function, including BrandManagement, Business Development, Clinical Development, Managed Markets,Sales, and Trade and Distribution. From its locations in Raleigh, NC,Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, NewYork City, Atlanta, and London, the firm serves clients throughout NorthAmerica, Europe, and Japan. For more information on Campbell Alliance, pleasevisit http://www.campbellalliance.com .-- Performing required organizational changes -- Implementing continuous process improvement -- Integrating reporting systems for serious adverse events -- Integrating other e-clinical systems with EDC
SOURCE Campbell Alliance
You May Also Like